First Affiliated Hospital of Guangxi Medical University clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   Treatment of Clonorchiasis in Guangxi With Albendazole…Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel

   Phase changed: Phase 4 → not applicable

   Also in this update: Primary completion pushed from Nov 30, 2026 to Feb 28, 2027; Study completion pushed from Dec 31, 2026 to Feb 28, 2027

   First Affiliated Hospital of Guangxi Medical University·Not applicable· NCT07074444· Registry history of NCT07074444 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

2. Notable

   UTOPIA · Unknown Time of Onset Stroke RePerfusIon Without…UTOPIA · Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

   Recruitment opened

   Also in this update: Trial sites expanded: 1 → 15 locations

   First Affiliated Hospital of Guangxi Medical University·Phase 3· NCT07475949· Registry history of NCT07475949 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.